Author

José Lázaro Pérez-Calle

LONG-TERM OUTCOMES OF ADALIMUMAB THERAPY IN ULCERATIVE COLITIS PATIENTS BY PRIOR ANTI-TNF EXPOSURE

Carlos Taxonera, Eva Iglesias, Jose Fernando Muñoz Nuñez, Marta Calvo, Manuel Barreiro de Acosta, David Busquets, Xavier Calvet Calvo, Antonio Rodríguez, Ramón Pajares, Javier Gisbert, Pilar López Serrano, José Lázaro Pérez-Calle, Angel Ponferrada, Cristobal de la Coba, Fernando Bermejo, Maria Chaparro Sanchez, Cristina Alb

EFFICACY AND SAFETY OF THE SEQUENTIAL USE OF A SECOND AND THIRD ANTI-TNF DRUG IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

María José Casanova, Maria Chaparro Sanchez, Miguel Mínguez, Elena Ricart, Carlos Taxonera, Santiago García-López, Jordi Guardiola Capon, Antonio López-San Román, Eva Iglesias, Pilar Nos, Beatriz Sicilia, Maria Isabel Vera, Joaquin Hinojosa, Sabino Riestra, Eugeni Domenech Morral, Xavier Calvet Calvo, José Lázaro Pérez-Call

COMPARISON OF ORIGINAL AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE AND MULTICENTRIC STUDY IN  SPAIN

Helena Martinez Lozano, Jose Miranda Bautista, keyla villa, Iago González Lama, Pilar López Serrano, José Lázaro Pérez-Calle, Pablo Pérez Galindo, Daniel Carpio López, VIRGINIA MATALLANA ROYO, Marta Calvo, Maria Isabel Vera, Ignacio Marín-Jiménez, Luis Menchén Viso

EARLY OPTIMIZATION OF GOLIMUMAB DOSE INDUCES DELAYED RESPONSE AND LONG-TERM CLINICAL BENEFIT IN ULCERATIVE COLITIS

Cristina Alba, Marisa Iborra, Marta María Bosca-Watts, Saioa Rubio, Oscar Nantes, Rebeca Higuera, Federico Bertoletti, Pilar Martínez-Montiel, Mónica Sierra-Ausin, Noemí Manceñido, José Lázaro Pérez-Calle, Alicia Algaba, David Olivares, Carlos Taxonera

Item 1 - 4 / 4
1